Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 INR | +0.72% | +2.64% | -29.79% |
Apr. 22 | Rajnish Wellness Turns to Profit in Fiscal Q4 | MT |
Apr. 19 | Rajnish Wellness Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Valuation
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Capitalization 1 | 696.1 | 87.16 | 52.58 | 881.8 | 12,757 |
Enterprise Value (EV) 1 | 727.3 | 163.5 | 137.2 | 962.7 | 12,855 |
P/E ratio | 15.3 x | -14.3 x | 52.7 x | 227 x | 2,773 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 1.67 x | 0.63 x | 0.39 x | 3.34 x | 49.4 x |
EV / Revenue | 1.75 x | 1.19 x | 1.02 x | 3.64 x | 49.8 x |
EV / EBITDA | 10.9 x | 122 x | 30.5 x | 561 x | 36,212 x |
EV / FCF | -6.08 x | -4.12 x | -16.1 x | -160 x | -584 x |
FCF Yield | -16.5% | -24.3% | -6.22% | -0.63% | -0.17% |
Price to Book | 3.13 x | 0.4 x | 0.24 x | 3.99 x | 15.4 x |
Nbr of stocks (in thousands) | 315,475 | 315,475 | 315,475 | 315,475 | 768,475 |
Reference price 2 | 2.207 | 0.2763 | 0.1667 | 2.795 | 16.60 |
Announcement Date | 9/26/19 | 12/5/20 | 9/8/21 | 9/8/22 | 9/2/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 275 | 416.7 | 137.5 | 134.3 | 264.4 | 258.3 |
EBITDA 1 | 44.5 | 66.5 | 1.344 | 4.503 | 1.715 | 0.355 |
EBIT 1 | 43.97 | 65.85 | 0.8142 | 3.946 | 1.653 | 0.23 |
Operating Margin | 15.99% | 15.8% | 0.59% | 2.94% | 0.63% | 0.09% |
Earnings before Tax (EBT) 1 | 36.37 | 58.7 | -6.168 | 1.155 | 5.489 | 6.324 |
Net income 1 | 24.34 | 42.35 | -6.087 | 0.9975 | 3.92 | 4.601 |
Net margin | 8.85% | 10.16% | -4.43% | 0.74% | 1.48% | 1.78% |
EPS 2 | 0.1057 | 0.1444 | -0.0193 | 0.003161 | 0.0123 | 0.005987 |
Free Cash Flow 1 | -37.04 | -119.6 | -39.7 | -8.533 | -6.021 | -22 |
FCF margin | -13.47% | -28.71% | -28.88% | -6.35% | -2.28% | -8.52% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/8/18 | 9/26/19 | 12/5/20 | 9/8/21 | 9/8/22 | 9/2/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 36.7 | 31.1 | 76.3 | 84.7 | 80.9 | 98.4 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.8243 x | 0.4683 x | 56.78 x | 18.8 x | 47.18 x | 277.3 x |
Free Cash Flow 1 | -37 | -120 | -39.7 | -8.53 | -6.02 | -22 |
ROE (net income / shareholders' equity) | 69.2% | 30% | -2.78% | 0.46% | 1.79% | 0.88% |
ROA (Net income/ Total Assets) | 21.2% | 16.7% | 0.16% | 0.73% | 0.3% | 0.02% |
Assets 1 | 115.1 | 253.7 | -3,880 | 136.4 | 1,321 | 21,500 |
Book Value Per Share 2 | 0.2600 | 0.7000 | 0.6900 | 0.6900 | 0.7000 | 1.080 |
Cash Flow per Share 2 | 0.0100 | 0.0500 | 0 | 0.0100 | 0.0300 | 0 |
Capex 1 | 1.1 | 0.71 | 0.03 | - | - | 0.31 |
Capex / Sales | 0.4% | 0.17% | 0.02% | - | - | 0.12% |
Announcement Date | 9/8/18 | 9/26/19 | 12/5/20 | 9/8/21 | 9/8/22 | 9/2/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-29.79% | 64.51M | |
+12.23% | 388B | |
+10.21% | 132B | |
+16.52% | 76.2B | |
-16.64% | 62.43B | |
-9.10% | 47.67B | |
-10.82% | 36.76B | |
+5.49% | 34.51B | |
+9.88% | 17.86B | |
+11.55% | 15.35B |
- Stock Market
- Equities
- RAJNISH Stock
- Financials Rajnish Wellness Limited